Paper28076844
Sulforaphane inhibits cancer stem-like cell properties and cisplatin resistance through miR-214-mediated downregulation of c-MYC in non-small cell lung cancer.
Li QQ and 8 others. Oncotarget, 2017. Cited by 63 papers, by iCite.
Cite this record
ConductScience Library. Sulforaphane inhibits cancer stem-like cell properties and cisplatin resistance through miR-214-mediated downregulation of c-MYC in non-small cell lung cancer. Papers, record 28076844. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28076844
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Sulforaphane inhibits cancer stem-like cell properties and cisplatin resistance through miR-214-mediated downregulation of c-MYC in non-small cell lung cancer.
- PubMed
Topics26
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Non-Small-Cell Lung | Major topic |
| Isothiocyanates | Major topic |
| Lung Neoplasms | Major topic |
| MicroRNAs | Major topic |
| Neoplastic Stem Cells | Major topic |
| Proto-Oncogene Proteins c-myc | Major topic |
| 3' Untranslated Regions | |
| A549 Cells | |
| Animals | |
| Antineoplastic Agents | |
| Blotting, Western | |
| Cell Line | |
| Cell Line, Tumor | |
| Cell Survival | |
| Cisplatin | |
| Down-Regulation | |
| Doxorubicin | |
| Drug Resistance, Neoplasm | |
| Gene Expression Regulation, Neoplastic | |
| Humans | |
| Mice, Inbred BALB C | |
| Mice, Nude | |
| Reverse Transcriptase Polymerase Chain Reaction | |
| Sulfoxides | |
| Xenograft Model Antitumor Assays | |
| beta Catenin |
Source PubMed
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17157785 | Radiation resistance and stem-like cells in brain tumors. | Cancer Cell | 2006 | https://conductscience.org/library/papers/17157785 | PubMed |
| 2 | 16064138 | Transcriptional regulation and transformation by Myc proteins. | Nat Rev Mol Cell Biol | 2005 | https://conductscience.org/library/papers/16064138 | PubMed |
| 3 | 9727977 | Identification of c-MYC as a target of the APC pathway. | Science | 1998 | https://conductscience.org/library/papers/9727977 | PubMed |
| 4 | 15944709 | c-Myc-regulated microRNAs modulate E2F1 expression. | Nature | 2005 | https://conductscience.org/library/papers/15944709 | PubMed |
| 5 | 18829980 | Sulforaphane targets pancreatic tumour-initiating cells by NF-kappaB-induced antiapoptotic signalling. | Gut | 2009 | https://conductscience.org/library/papers/18829980 | PubMed |
| 6 | 10499637 | Increase of cisplatin sensitivity by c-myc antisense oligodeoxynucleotides in a human metastatic melanoma inherently resistant to cisplatin. | Clin Cancer Res | 1999 | https://conductscience.org/library/papers/10499637 | PubMed |
| 7 | 19276181 | Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. | Mol Cancer Res | 2009 | https://conductscience.org/library/papers/19276181 | PubMed |
| 8 | 11221849 | A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to Ras and Raf transformation. | Cancer Res | 2001 | https://conductscience.org/library/papers/11221849 | PubMed |
| 9 | 20388854 | Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells. | Clin Cancer Res | 2010 | https://conductscience.org/library/papers/20388854 | PubMed |
| 10 | 21466425 | Phytochemicals resveratrol and sulforaphane as potential agents for enhancing the anti-tumor activities of conventional cancer therapies. | Curr Pharm Biotechnol | 2012 | https://conductscience.org/library/papers/21466425 | PubMed |
| 11 | 19805294 | Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. | Proc Natl Acad Sci U S A | 2009 | https://conductscience.org/library/papers/19805294 | PubMed |
| 12 | 9858526 | c-Myc target genes involved in cell growth, apoptosis, and metabolism. | Mol Cell Biol | 1999 | https://conductscience.org/library/papers/9858526 | PubMed |
| 13 | 19474385 | Cancer statistics, 2009. | CA Cancer J Clin | 2009 | https://conductscience.org/library/papers/19474385 | PubMed |
| 14 | 18049477 | Identification and expansion of the tumorigenic lung cancer stem cell population. | Cell Death Differ | 2008 | https://conductscience.org/library/papers/18049477 | PubMed |
| 15 | 26234674 | Overexpression of miR-214-3p in esophageal squamous cancer cells enhances sensitivity to cisplatin by targeting survivin directly and indirectly through CUG-BP1. | Oncogene | 2016 | https://conductscience.org/library/papers/26234674 | PubMed |
| 16 | 17134937 | Sulforaphane as a promising molecule for fighting cancer. | Mutat Res | 2007 | https://conductscience.org/library/papers/17134937 | PubMed |
| 17 | 18716624 | Modelling Myc inhibition as a cancer therapy. | Nature | 2008 | https://conductscience.org/library/papers/18716624 | PubMed |
| 18 | 18371393 | ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. | Cell Stem Cell | 2007 | https://conductscience.org/library/papers/18371393 | PubMed |
| 19 | 16904174 | Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. | Cell | 2006 | https://conductscience.org/library/papers/16904174 | PubMed |
| 20 | 22962603 | MiR-214 targets β-catenin pathway to suppress invasion, stem-like traits and recurrence of human hepatocellular carcinoma. | PLoS One | 2012 | https://conductscience.org/library/papers/22962603 | PubMed |
Cited by35
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 63 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41594902 | Sulforaphane as a Multi-Scale Mechano-Modulator in Cancer: An Integrative Perspective. | Biology (Basel) | 2026 | https://conductscience.org/library/papers/41594902 | PubMed |
| 41060333 | Sulforaphane from broccoli, an epigenetic modulator in cancer cells. | Discov Oncol | 2025 | https://conductscience.org/library/papers/41060333 | PubMed |
| 39760839 | Synergistic Inhibition of Breast Carcinoma Cell Proliferation by Quercetin and Sulforaphane via Activation of the ERK/MAPK Pathway. | Cell Biochem Biophys | 2025 | https://conductscience.org/library/papers/39760839 | PubMed |
| 39519082 | Sulforaphane Attenuates Ethanol-Induced Teratogenesis and Dysangiogenesis in Zebrafish Embryos. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39519082 | PubMed |
| 38972997 | MicroRNAs and the Mediterranean diet: a nutri-omics perspective for lung cancer. | J Transl Med | 2024 | https://conductscience.org/library/papers/38972997 | PubMed |
| 38892270 | Ferroptosis-Regulated Natural Products and miRNAs and Their Potential Targeting to Ferroptosis and Exosome Biogenesis. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38892270 | PubMed |
| 38474751 | Sulforaphane Inhibits Adhesion and Migration of Cisplatin- and Gemcitabine-Resistant Bladder Cancer Cells In Vitro. | Nutrients | 2024 | https://conductscience.org/library/papers/38474751 | PubMed |
| 38254735 | Harnessing Sulforaphane Potential as a Chemosensitizing Agent: A Comprehensive Review. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38254735 | PubMed |
| 36933561 | A complex microRNA regulatory network may control the HCP5/UTP3/c-Myc/VAMP3 signaling axis. | Mol Ther | 2023 | https://conductscience.org/library/papers/36933561 | PubMed |
| 36776295 | Sulforaphane: An emergent anti-cancer stem cell agent. | Front Oncol | 2023 | https://conductscience.org/library/papers/36776295 | PubMed |
| 36498571 | Destroying the Shield of Cancer Stem Cells: Natural Compounds as Promising Players in Cancer Therapy. | J Clin Med | 2022 | https://conductscience.org/library/papers/36498571 | PubMed |
| 35957877 | The metabolic addiction of cancer stem cells. | Front Oncol | 2022 | https://conductscience.org/library/papers/35957877 | PubMed |
| 35886942 | MicroRNAs as Predictors of Lung-Cancer Resistance and Sensitivity to Cisplatin. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35886942 | PubMed |
| 34946741 | Caffeine Induces G0/G1 Cell Cycle Arrest and Inhibits Migration through Integrin αv, β3, and FAK/Akt/c-Myc Signaling Pathway. | Molecules | 2021 | https://conductscience.org/library/papers/34946741 | PubMed |
| 34832864 | Multiple Antitumor Molecular Mechanisms Are Activated by a Fully Synthetic and Stabilized Pharmaceutical Product Delivering the Active Compound Sulforaphane (SFX-01) in Preclinical Model of Human Glioblastoma. | Pharmaceuticals (Basel) | 2021 | https://conductscience.org/library/papers/34832864 | PubMed |
| 34295245 | Two Worlds Colliding: The Interplay Between Natural Compounds and Non-Coding Transcripts in Cancer Therapy. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/34295245 | PubMed |
| 33925297 | Novel Primary Human Cancer Stem-Like Cell Populations from Non-Small Cell Lung Cancer: Inhibition of Cell Survival by Targeting NF-κB and MYC Signaling. | Cells | 2021 | https://conductscience.org/library/papers/33925297 | PubMed |
| 33672261 | Therapeutic Targeting of MicroRNAs in the Tumor Microenvironment. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33672261 | PubMed |
| 33183321 | Non coding RNAs as the critical factors in chemo resistance of bladder tumor cells. | Diagn Pathol | 2020 | https://conductscience.org/library/papers/33183321 | PubMed |
| 33055265 | Epigenetics/Epigenomics and Prevention of Early Stages of Cancer by Isothiocyanates. | Cancer Prev Res (Phila) | 2021 | https://conductscience.org/library/papers/33055265 | PubMed |
Genes17
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28076844
GET https://conductscience.org/api/papers/v1/28076844/references?page=2